The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
cis-2-(2,6-Dimethoxyphenoxy)-N-((3-phenyl-1,4-dioxan-2-yl)methyl)ethanamine ID: ALA4461115
PubChem CID: 155528183
Max Phase: Preclinical
Molecular Formula: C21H27NO5
Molecular Weight: 373.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(OC)c1OCCNC[C@H]1OCCO[C@H]1c1ccccc1
Standard InChI: InChI=1S/C21H27NO5/c1-23-17-9-6-10-18(24-2)21(17)26-12-11-22-15-19-20(27-14-13-25-19)16-7-4-3-5-8-16/h3-10,19-20,22H,11-15H2,1-2H3/t19-,20+/m1/s1
Standard InChI Key: FIDRRYSVIRIHOV-UXHICEINSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
32.8432 -17.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8432 -16.2019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5558 -17.4373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2643 -17.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2643 -16.2019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5558 -15.7873 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.9787 -17.4425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6944 -17.0290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.4088 -17.4445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1244 -17.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8389 -17.4466 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.5545 -17.0331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2613 -17.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9765 -17.0399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9781 -16.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2587 -15.8027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5506 -16.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9769 -15.7955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6910 -16.2098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4067 -15.8022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4096 -14.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6908 -14.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9779 -14.9740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8382 -15.8059 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.8353 -14.9850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2563 -18.2737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.5429 -18.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 6 1 0
1 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
4 7 1 1
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
5 18 1 1
17 24 1 0
24 25 1 0
13 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.45Molecular Weight (Monoisotopic): 373.1889AlogP: 2.83#Rotatable Bonds: 9Polar Surface Area: 58.18Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.89CX LogP: 2.71CX LogD: 1.22Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: 0.07
References 1. Del Bello F, Bonifazi A, Giorgioni G, Quaglia W, Amantini C, Morelli MB, Santoni G, Battiti FO, Vistoli G, Cilia A, Piergentili A.. (2019) Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells., 168 [PMID:30844609 ] [10.1016/j.ejmech.2019.02.056 ]